CN1078468C - 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途 - Google Patents
叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途 Download PDFInfo
- Publication number
- CN1078468C CN1078468C CN98115915A CN98115915A CN1078468C CN 1078468 C CN1078468 C CN 1078468C CN 98115915 A CN98115915 A CN 98115915A CN 98115915 A CN98115915 A CN 98115915A CN 1078468 C CN1078468 C CN 1078468C
- Authority
- CN
- China
- Prior art keywords
- sodium copper
- sodium
- ulcer
- copper chlorophllin
- gastric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- ZIALXKMBHWELGF-UHFFFAOYSA-N [Na].[Cu] Chemical compound [Na].[Cu] ZIALXKMBHWELGF-UHFFFAOYSA-N 0.000 claims description 47
- 230000006378 damage Effects 0.000 claims description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 208000027418 Wounds and injury Diseases 0.000 claims description 7
- 208000014674 injury Diseases 0.000 claims description 7
- 210000004877 mucosa Anatomy 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000391 magnesium silicate Substances 0.000 claims description 4
- 229910052919 magnesium silicate Inorganic materials 0.000 claims description 4
- 235000019792 magnesium silicate Nutrition 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920002101 Chitin Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- 239000003797 essential amino acid Substances 0.000 claims description 2
- 235000020776 essential amino acid Nutrition 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 claims 1
- -1 electuary Substances 0.000 claims 1
- JBJWASZNUJCEKT-UHFFFAOYSA-M sodium;hydroxide;hydrate Chemical compound O.[OH-].[Na+] JBJWASZNUJCEKT-UHFFFAOYSA-M 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 10
- 201000005917 gastric ulcer Diseases 0.000 abstract description 10
- 210000001156 gastric mucosa Anatomy 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 208000007502 anemia Diseases 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 230000001954 sterilising effect Effects 0.000 abstract description 4
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 230000002155 anti-virotic effect Effects 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 230000003449 preventive effect Effects 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 abstract 2
- 229940079841 sodium copper chlorophyllin Drugs 0.000 abstract 2
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 description 23
- 231100000397 ulcer Toxicity 0.000 description 23
- 230000000694 effects Effects 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 229930002875 chlorophyll Natural products 0.000 description 9
- 235000019804 chlorophyll Nutrition 0.000 description 9
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 9
- 239000002775 capsule Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 229960000905 indomethacin Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 206010061164 Gastric mucosal lesion Diseases 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- 230000004223 radioprotective effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 2
- 229960001380 cimetidine Drugs 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000439 acute liver injury Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 231100000012 chronic liver injury Toxicity 0.000 description 1
- 229940084460 cimetidine 100 mg Drugs 0.000 description 1
- 239000010883 coal ash Substances 0.000 description 1
- 239000002817 coal dust Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940039412 ketalar Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000007540 photo-reduction reaction Methods 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007944 soluble tablet Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98115915A CN1078468C (zh) | 1998-07-02 | 1998-07-02 | 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98115915A CN1078468C (zh) | 1998-07-02 | 1998-07-02 | 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1212151A CN1212151A (zh) | 1999-03-31 |
CN1078468C true CN1078468C (zh) | 2002-01-30 |
Family
ID=5224853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98115915A Expired - Lifetime CN1078468C (zh) | 1998-07-02 | 1998-07-02 | 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1078468C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100333716C (zh) * | 2005-11-04 | 2007-08-29 | 余内逊 | 一种微米糖参玉叶蜂胶铬药降糖益胃养生颗粒、胶囊与片剂制备方法 |
CN102462671A (zh) * | 2010-11-18 | 2012-05-23 | 何国增 | 叶绿素铜钠胶囊的制备方法 |
CN105250267B (zh) * | 2015-10-12 | 2017-11-07 | 成都通德药业有限公司 | 叶绿素铜钠的用途 |
CN105147673A (zh) * | 2015-10-12 | 2015-12-16 | 成都通德药业有限公司 | 叶绿素铜钠在制备治疗肝病药物中的新用途 |
-
1998
- 1998-07-02 CN CN98115915A patent/CN1078468C/zh not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
《医学研究通讯》1991年第20卷第4期 1991.4.30 魏克民等叶绿素铜盐治疗慢性再生障碍性贫血的临床报道 * |
Also Published As
Publication number | Publication date |
---|---|
CN1212151A (zh) | 1999-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1267106C (zh) | 活化二甲硅油/无水磷酸钙组合物 | |
JPH11199497A (ja) | 生体刺激剤 | |
CN103211801A (zh) | 一种在口腔中快速溶解的膜剂及其制备方法 | |
Zhang et al. | Immunomodulatory activity of a fructooligosaccharide isolated from burdock roots | |
CN1078468C (zh) | 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途 | |
CN1742741A (zh) | 含氨基葡萄糖和钙剂及维生素d的药物组合物及其应用 | |
CN1741807A (zh) | 抗溃疡草药组合物 | |
CN1434052A (zh) | 老鹳草总黄酮提取物及其在制备抗病毒药物中的用途 | |
CN1179726C (zh) | 柚皮苷在制备支持性治疗非典型性肺炎药物中的应用 | |
CN1172433A (zh) | 胃溃宁制剂 | |
CN1864733A (zh) | 治疗口腔炎症的中成药 | |
KR101254511B1 (ko) | 위장약 조성물 | |
CN1430967A (zh) | 柚皮苷用于制备治疗急、慢性支气管炎的药物 | |
CN1259939C (zh) | 一种治疗口腔疾病的中药制剂及制备方法 | |
KR101779513B1 (ko) | 애엽의 이소프로판올 추출물을 포함하는 약제학적 조성물 | |
CN1686091A (zh) | 二苯基庚酮类化合物的组合物及它的用途 | |
JP4786166B2 (ja) | 制酸剤組成物 | |
CN1240426C (zh) | 治疗口腔溃疡的中成药 | |
CN1799603A (zh) | 一种治疗风湿或类风湿的中药组合物及其制备方法 | |
CN1282479C (zh) | 一种治疗口腔粘膜病的药物组合物及其制备方法 | |
CN1966047A (zh) | 一种治疗前列腺增生的中药制剂 | |
CN1327386A (zh) | 抗hiv感染症剂及hiv感染症的治疗方法 | |
CN1679616A (zh) | 一种用于胃炎治疗的复方片剂及其制备方法 | |
CN1535972A (zh) | 一种新的化合物及其制备方法和以该化合物为活性成分的药物制剂及其作用、用途 | |
CN1562210A (zh) | 地榆口腔崩解片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINING FENGMING CHLOROPHYLL CO., LTD. Free format text: FORMER OWNER: XU DEYU Effective date: 20100804 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200433 ROOM 1002, NO.4, LANE 28, ZHONGYUAN ROAD, SHANGHAI CITY TO: 314400 NO.78, YOUCHE ROAD, ZHOUWANGMIAO TOWN, HAINING CITY, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100804 Address after: 314400 Zhejiang city of Haining Province Zhou Wang Miao Zhen you Che Road No. 78 Patentee after: Haining Fengming Chlorophyll Co., Ltd. Address before: 1002, room 4, No. 28, Lane 200433, Zhongyuan Road, Shanghai Patentee before: Xu Deyu |
|
CX01 | Expiry of patent term |
Granted publication date: 20020130 |
|
CX01 | Expiry of patent term |